ActualMeds Receives Top Award at HIMSS14 Venture+ Forum

ActualMeds, a provider of web-based platforms to facilitate patient data collection and automate coordination of care for medication management in patients with chronic diseases, was selected as the winner of the 2014 Venture+ Forum pitch contest for startups at the HIMSS Annual Conference.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

East Hartford, Conn. (PRWEB) March 14, 2014

ActualMeds, a provider of web-based platforms to facilitate patient data collection and automate coordination of care for medication management in patients with chronic diseases, today announced it was selected as the winner of the 2014 Venture+ Forum pitch contest for startups at the HIMSS Annual Conference.

At this year’s Venture+ Forum, ActualMeds was one of 20 pre-selected companies that were given the opportunity to pitch their products, services and solutions to a panel of leading experts in healthcare investment, business and technology.

"Many times, the only opportunity a healthcare provider has to engage complex patients is at the point of care,” said Patricia Meisner, CEO and cofounder of ActualMeds. “ActualMeds provides the most up-to-date records of current medication, which can be critical in avoiding medication-related hospitalizations and re-admissions. We provide the best possible medication history for a patient and make it available to healthcare professionals at the right time and place to inform their treatment and intervention choices.”

ActualMeds provides “medication reconciliation on demand” at point of care and seamlessly combines medication information from the electronic health records, prescription claims, and structured patient interviews, ActualMeds produces the most accurate and current medication history and supplies the health care team with that information. For payers and providers with high-risk patients, such as the elderly and chronically ill, Actual Meds helps to improve operating efficiencies, quality metrics and outcomes.

“The Venture+ Forum aims to bring the newest, most promising healthcare companies to the forefront at the HIMSS annual conference, as well as at the mHealth Summit,” said Rich Scarfo, Vice President, Events at the Personal Connected Health Alliance (PCHA) – a collaboration of HIMSS, Continua Health Alliance, and the mHealth Summit. “In line with the innovative spirit of the Venture+ Forum, ActualMeds demonstrates the ability to disrupt the healthcare ecosystem and drive more efficient and effective care through their technologies.”

The Venture+ Forum offers a unique platform for showcasing transformative technology and for exploring investment opportunities to bring healthcare innovations to market. The Venture+ Forum is focused on promoting business-building collaborations and fostering healthcare innovation by connecting investors, entrepreneurs and strategic partners.

"It is a great honor to be the HIMSS14 Venture+ Forum winner,” said Meisner. “Through the Venture+ Forum, the HIMSS organization is providing high visibility to innovators who are addressing challenges that are fundamental to the transformation of healthcare. This kind of visibility can be catalytic to success of an early-stage company like ActualMeds."

About the Venture+ Forum
Established in 2007, the Venture+ Forum, presented by the Personal Connected Health Alliance (PCHA) – a collaboration of HIMSS, Continua Health Alliance, and the mHealth Summit – is a one-day event that spotlights new and emerging companies and showcases the hottest mobile health and health IT technologies for improving healthcare delivery and patient outcomes. The Venture+ Forum connects entrepreneurs, investors and strategic partners to foster business-building collaborations and to bring healthcare innovations to market.

About ActualMeds
Headquartered in East Hartford, Conn., ActualMeds is a health care information technology company focused on providing web-based and mobile solutions to enable team-based medication management and reconciliation at the point of care. ActualMeds engages with large healthcare systems to demonstrate that the ability to conduct automated medication reconciliation in a variety of settings along the care continuum, which can help prevent hospitalizations and reduce re-admissions for chronically-ill patients. For more information, visit http://www.actualmeds.com.

About HIMSS
HIMSS is a global, cause-based, not-for-profit organization focused on better health through information technology (IT). HIMSS leads efforts to optimize health engagements and care outcomes using information technology.

HIMSS is a cause-based, global enterprise producing health IT thought leadership, education, events, market research and media services around the world. Founded in 1961, HIMSS encompasses more than 52,000 individuals, of which more than two-thirds work in healthcare provider, governmental and not-for-profit organizations across the globe, plus over 600 corporations and 250 not-for-profit partner organizations, that share this cause. HIMSS, headquartered in Chicago, serves the global health IT community with additional offices in the United States, Europe, and Asia.

Media contact:
Patricia Meisner
ActualMeds
Phone: 508.864.9385
Email: pmeisner(at)actualmeds(dot)com


Contact